| 000 | 01661 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516025222.0 | ||
| 264 | 0 | _c20110628 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1476-6256 | ||
| 024 | 7 |
_a10.1093/aje/kwq437 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaugherty, Sarah E | |
| 245 | 0 | 0 |
_aNonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis. _h[electronic resource] |
| 260 |
_bAmerican journal of epidemiology _cApr 2011 |
||
| 300 |
_a721-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xepidemiology |
| 700 | 1 | _aPfeiffer, Ruth M | |
| 700 | 1 | _aSigurdson, Alice J | |
| 700 | 1 | _aHayes, Richard B | |
| 700 | 1 | _aLeitzmann, Michael | |
| 700 | 1 | _aSchatzkin, Arthur | |
| 700 | 1 | _aHollenbeck, Albert R | |
| 700 | 1 | _aSilverman, Debra T | |
| 773 | 0 |
_tAmerican journal of epidemiology _gvol. 173 _gno. 7 _gp. 721-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/aje/kwq437 _zAvailable from publisher's website |
| 999 |
_c20640982 _d20640982 |
||